For health care professionals in EUROPE except those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
AF is a progressive disease that requires both rhythm management and ongoing stroke prevention. Early referral and comprehensive management can help patients access the most appropriate treatment options throughout the continuum of care.
Visit us at Booth #H100 to discover the latest clinical evidence and innovations in AF management, from rhythm control to stroke prevention.
Managing AF requires both rhythm control and stroke prevention.
Although rhythm control is an important treatment goal, underlying stroke risk may still remain. Stroke prevention should therefore be a lifelong consideration in patients with AF.
Patients with AF require lifelong management as symptoms, disease progression, and stroke risk evolve over time.
Catheter ablation has a Class IA recommendation by ESC1 as a first-line treatment option for selected categories of AF patients.
Early intervention may:
For certain AF patients, Left Atrial Appendage Closure (LAAC) may be a pragmatic alternative for stroke prevention.
There is a growing body of evidence to support referrals' decision making for the therapy of patients who are not suitable for long term oral anticoagulation
Learn about Stroke Prevention
From rhythm control to stroke prevention, patients benefit from access to the full spectrum of evidence-based AF management options.
Visit us at ESC Booth H100!
Refernces:
1. Isabelle C Van Gelder et al. ESC Scientific Document Group , 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO), European Heart Journal, Volume 45, Issue 36, 21 September 2024, Pages 3314–3414, https://doi.org/10.1093/eurheartj/ehae176
CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
